According to CoinMeta, and based on documents from Bloomberg and the U.S. Securities and Exchange Commission (SEC), iambic raised $150 million in its initial public offering (IPO) in the United States, selling 9.375 million shares. The company plans to trade on NASDAQ under the stock code IAM. Backed by NVIDIA, it focuses on the research and development of artificial intelligence drugs.